Initial Approach for a Patient with Low Free Testosterone Levels
The initial approach for a patient with low free testosterone levels should include confirmation of the diagnosis with repeat morning testosterone measurements, followed by measurement of luteinizing hormone (LH) levels to determine the etiology of testosterone deficiency, before considering treatment options. 1, 2
Diagnostic Confirmation
Confirm the diagnosis:
Measure luteinizing hormone (LH) levels:
Additional testing based on LH results:
- If LH is low or low/normal with low testosterone:
- If LH is elevated (primary hypogonadism):
- Consider causes such as testicular injury, Klinefelter syndrome, or other primary testicular disorders
Risk Assessment
Evaluate for conditions associated with increased risk of testosterone deficiency:
- Unexplained anemia
- Bone density loss
- Diabetes
- History of chemotherapy or radiation therapy to testes
- HIV
- Chronic narcotic use
- Infertility
- Pituitary disorders
- Chronic corticosteroid use 1
Additional Testing Considerations
Measure serum estradiol:
- Indicated in patients who present with breast symptoms or gynecomastia 1
- Elevated levels may require endocrinology referral
Reproductive health evaluation:
- For men interested in fertility, perform testicular exam and measure follicle-stimulating hormone (FSH) 1
- Consider semen analysis if FSH is elevated
Metabolic assessment:
Initial Management Approach
Lifestyle modifications (first-line approach):
- Weight management (5-10% weight loss can significantly improve testosterone levels)
- Regular exercise (150 minutes of moderate-intensity exercise weekly)
- Mediterranean diet
- Limited alcohol consumption 2
Consider testosterone replacement therapy if symptomatic and diagnosis confirmed:
Common Pitfalls to Avoid
Diagnostic pitfalls:
Treatment pitfalls:
Remember that total testosterone between 280-350 ng/dL is not sensitive enough to reliably exclude hypogonadism, and free testosterone measurement is particularly important in these borderline cases 5. The combination of symptoms and biochemical confirmation should guide treatment decisions.